Literature DB >> 12050275

Progesterone withdrawal and estrogen activation in human parturition are coordinated by progesterone receptor A expression in the myometrium.

Sam Mesiano1, Eng-Cheng Chan, John T Fitter, Kenneth Kwek, George Yeo, Roger Smith.   

Abstract

In human parturition, progesterone withdrawal and estrogen activation are not mediated by changes in progesterone and estrogen levels. Instead, these events could be facilitated by changes in the responsiveness of the myometrium to progesterone and estrogens via changes in PR and ER expression. We hypothesized that functional progesterone withdrawal occurs by increased expression of the type A PR (PR-A), which suppresses progesterone responsiveness, and that functional estrogen activation occurs by increased myometrial expression of ERalpha and/or ERbeta. To test this hypothesis we compared the abundance of mRNAs (assessed by quantitative RT-PCR) encoding PR-A, PR-B, ERalpha, and ERbeta in nonlaboring (n = 12) and laboring (n = 12) term human myometrium. PR-A, PR-B, the PR-A/PR-B mRNA ratio, and ERalpha mRNA were significantly increased in laboring myometrium, whereas ERbeta mRNA was low and unchanged. The PR-A/PR-B mRNA ratio correlated positively with ERalpha mRNA levels in nonlaboring myometrium and with HOXA10 mRNA levels in laboring myometrium. Because progesterone inhibits ERalpha and HOXA10 expression, these findings indicate that myometrial progesterone responsiveness is inversely related to the extent of expression of PR-A relative to PR-B. ERalpha mRNA levels correlated positively with cyclooxygenase type 2 and oxytocin receptor mRNA levels in nonlaboring myometrium, indicating that the increase in ERalpha expression is directly associated with the activation of contraction-associated genes and estrogen responsiveness. These data indicate that in the term human myometrium, responsiveness to progesterone is controlled by the expression of PR-A relative to PR-B and that a significant increase in this ratio underlies functional progesterone withdrawal. Our data also indicate that functional estrogen activation occurs by increased expression of ERalpha and is linked to functional progesterone withdrawal. Interaction between the PR and ER systems in the human myometrium may be critical for the control of human parturition and the coordination of progesterone withdrawal and estrogen activation required for parturition.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12050275     DOI: 10.1210/jcem.87.6.8609

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  109 in total

1.  Neonatal DNA methylation patterns associate with gestational age.

Authors:  James W Schroeder; Karen N Conneely; Joseph C Cubells; Varun Kilaru; D Jeffrey Newport; Bettina T Knight; Zachary N Stowe; Patricia A Brennan; Julia Krushkal; Frances A Tylavsky; Robert N Taylor; Ronald M Adkins; Alicia K Smith
Journal:  Epigenetics       Date:  2011-12       Impact factor: 4.528

2.  Progesterone receptor-A and -B have opposite effects on proinflammatory gene expression in human myometrial cells: implications for progesterone actions in human pregnancy and parturition.

Authors:  Huiqing Tan; Lijuan Yi; Neal S Rote; William W Hurd; Sam Mesiano
Journal:  J Clin Endocrinol Metab       Date:  2012-03-14       Impact factor: 5.958

Review 3.  Development and function of the human fetal adrenal cortex: a key component in the feto-placental unit.

Authors:  Hitoshi Ishimoto; Robert B Jaffe
Journal:  Endocr Rev       Date:  2010-11-04       Impact factor: 19.871

4.  miR-200 family and targets, ZEB1 and ZEB2, modulate uterine quiescence and contractility during pregnancy and labor.

Authors:  Nora E Renthal; Chien-Cheng Chen; Koriand'r C Williams; Robert D Gerard; Janine Prange-Kiel; Carole R Mendelson
Journal:  Proc Natl Acad Sci U S A       Date:  2010-11-15       Impact factor: 11.205

Review 5.  Molecular Regulation of Parturition: A Myometrial Perspective.

Authors:  Nora E Renthal; Koriand'r C Williams; Alina P Montalbano; Chien-Cheng Chen; Lu Gao; Carole R Mendelson
Journal:  Cold Spring Harb Perspect Med       Date:  2015-09-03       Impact factor: 6.915

Review 6.  Immunomodulatory effects of sex hormones: requirements for pregnancy and relevance in melanoma.

Authors:  Elizabeth Ann L Enninga; Shernan G Holtan; Douglas J Creedon; Roxana S Dronca; Wendy K Nevala; Simona Ognjanovic; Svetomir N Markovic
Journal:  Mayo Clin Proc       Date:  2014-04       Impact factor: 7.616

7.  Unique suppression of prostaglandin H synthase-2 expression by inhibition of histone deacetylation, specifically in human amnion but not adjacent choriodecidua.

Authors:  Murray D Mitchell
Journal:  Mol Biol Cell       Date:  2005-10-26       Impact factor: 4.138

Review 8.  The preterm parturition syndrome.

Authors:  R Romero; J Espinoza; J P Kusanovic; F Gotsch; S Hassan; O Erez; T Chaiworapongsa; M Mazor
Journal:  BJOG       Date:  2006-12       Impact factor: 6.531

9.  Preterm birth without progesterone withdrawal in 15-hydroxyprostaglandin dehydrogenase hypomorphic mice.

Authors:  Jeffrey D Roizen; Minoru Asada; Min Tong; Hsin-Hsiung Tai; Louis J Muglia
Journal:  Mol Endocrinol       Date:  2007-09-13

Review 10.  Fetal-to-maternal signaling in the timing of birth.

Authors:  Carole R Mendelson; Alina P Montalbano; Lu Gao
Journal:  J Steroid Biochem Mol Biol       Date:  2016-09-11       Impact factor: 4.292

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.